Results 301 to 310 of about 4,905,490 (375)

EFFECT OF HALOTHANE, ENFLURANE AND ISOFLURANE ON CAROTID BODY CHEMORECEPTOR ACTIVITY IN THE RABBIT AND THE CAT

, 1989
J Ponte, C L Sadler
openalex   +1 more source

Distribution and morphology of serotonin transporter-immunoreactive type I cells in the rat carotid body. [PDF]

Anat Rec (Hoboken)
Yokoyama T, Abdali SS, Nakamuta N, Yamamoto Y.   +3 more
europepmc   +1 more source

Site‐specific m6A‐miR‐494‐3p, not unmethylated miR‐494‐3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis

British Journal of Pharmacology, EarlyView.
Background and Purpose Intracranial atherosclerosis is one of the most common causes of ischaemic stroke. However, there is a substantial knowledge gap on the development of intracranial atherosclerosis. Intracranial arteries are characterized by an upregulation of tight junctions between endothelial cells, which control endothelial permeability.
Tamar Woudenberg, M. Leontien van der Bent, Veerle Kremer, Ingeborg S. E. Waas, Mat J. A. P. Daemen, Reinier A. Boon, Paul H. A. Quax, A. Yaël Nossent   +7 more
wiley   +1 more source

Pediatric carotid body tumors: A case report and systematic review. [PDF]

J Vasc Surg Cases Innov Tech
Alanezi T, Bin Onayq AI, Al-Omran M.
europepmc   +1 more source

pH regulation in adult rat carotid body glomus cells. Importance of extracellular pH, sodium, and potassium.

, 1992
Timothy J. Wilding, Bin Cheng, A. Roos
openalex   +1 more source

Assessment of the molecular mechanisms of drug‐induced hidden cardiotoxicity by a multi‐omics approach: The example of rofecoxib

British Journal of Pharmacology, EarlyView.
Background and Purpose Hidden cardiotoxicity is defined as drug‐induced cardiotoxicity that becomes obvious only in the presence of comorbidities. However, the molecular mechanisms of hidden cardiotoxicity are not always known. Therefore, unbiased multi‐omics approaches could assist in revealing regulatory pathways.
Bennet Y. Weber, Gábor B. Brenner, Barnabás Váradi, Bence Ágg, Csenger Kovácsházi, Olivér M. Balogh, Donagh Egan, Kieran Wynne, David Matallanas, Rainer Schulz, Péter Ferdinandy, Zoltán Giricz, Anikó Görbe   +12 more
wiley   +1 more source

Challenges in the Management of Massive Carotid Body Tumor. [PDF]

Case Rep Otolaryngol
Olusoga-Peters O, Akinola MA, Nwadiokwu JI, Oguntade F.   +3 more
europepmc   +1 more source

α-Synuclein Pathology in the Carotid Body: Experimental Evidence for a possible Contributor to Respiratory Impairment in Parkinson's Disease. [PDF]

Mov Disord
Emmi A, Macchi V, Stocco E, Tushevski A, Antonini A, De Caro R, Porzionato A.   +6 more
europepmc   +1 more source

The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome‐Lysosome Fusion

Cell Proliferation, EarlyView.
The present study revealed the neuroprotective effect of ginsenoside Rg1 against cerebral ischemia–reperfusion injury through inhibition of mitophagy via blocking mitophagosome‐lysosome fusion both in vivo and in vitro models. ABSTRACT Ginsenoside Rg1 has shown promise in ameliorating cerebral ischemia–reperfusion injury (CIRI).
Lin Ai, Hangui Ren, Yuan Wang, Mengfan Liu, Yufei Qiu, Jiling Feng, Rongchen Dai, Wang Fu, Yongpeng Wang, Zhichao Xi, Hongxi Xu, Feng Wang   +11 more
wiley   +1 more source

Percutaneous preoperative embolization with onyx in the management of a carotid body tumor: A case report. [PDF]

Radiol Case Rep
Villanova I, Zimatore DS, Dell'Atti C, Lucarelli NM, Lorusso G, De Toma V, De Marco L, Morelli C, Maggialetti N, Stabile Ianora AA.   +9 more
europepmc   +1 more source